ChemoCentryx’s ‘Avacopan’ Drug Gets US FDA Approval to Treat Rare Autoimmune Disease
On Friday, 8th October 2021, the company ChemoCentryx Inc., said, the health agency of the United States has given the authorization to the company’s lead drug for the treatment of a rare and fatal autoimmune disease, that has been sending the shares of the biopharmaceutical company up by more than 70 percent. Thomas Schall, chief […]
Continue Reading